Instruments for State Regulation of the Market of Plant Cell Concentrates Based on Medicinal Herbs

The article examines the prospects and marketability of plant cell concentrates based on medicinal herbs in the context of import substitution policy. The need to switch these products from the category of food concentrates to the status of medicines is proved. A key aspect of such a transition is optimization of state regulation for pharmaceutical industry through the introduction of new medicines on the market that reduce the incidence rate in the country. The legal features of food concentrates and medicines regulation are considered, which strengthen the expediency of softening the threshold for the entry of medicinal products manufacturers into the pharmaceutical market by the state. The article presents data on the demand of Russians for medicines from 2020 to 2023, taking into account the most significant social events. The conclusion is formulated that the increasing demand can be satisfied by new domestic participants in the pharmaceutical market. Based on the analysis of the turnover of the Russian Federation pharmaceutical market from 2020 to 2023, the need to change state regulation towards softening the entry threshold for new medicines is defined. The paper also presents the dynamics of the Russian Federation pharmaceutical market, which makes it possible to highlight the urgent need for domestic pharmaceutical products and to provide a system for improving the population’s health by reducing dependence on imports of medicines, raw materials and other related products. The study of the theoretical base made it possible to determine that state regulation of the market of the products in question should be aimed at ensuring constant demand from Russians, uniting participants of the industry into industrial clusters, expanding regulation beyond the industrial potential, taking into account risks for the development of the studied medicinal products based on a weak connection with the instruments of state support for the pharmaceutical industry. In conclusion, recommendations for state regulation of the studied products market are provided as well as the positive consequences for the national economy and the health improvement system of Russians are highlighted.

1. Alekanov A.S. (2021) Directions of State Financial Regulation of the Pharmaceutical Market Abroad and Russian Practice of Import Substitution. Finansovyye rynki i banki. No. 3. P. 7–11.

2. Braithwaite J. (2020) Meta Governance of Path Dependencies: Regulation, Welfare, and Markets. The Annals of the American Academy of Political and Social Science. Vol. 691. Is. 1. P. 30–49. DOI: 10.1177/0002716220949193

3. Broadbent M. (2020) Covid-19 Demand Shock and Preparedness Response: Securing Medical Supply Chains: The Trusted Trade Partner Network. Washington, D.C.: Center for Strategic and International Studies (CSIS).

4. Etz A.V. (2020) The Main Measures of the System of State Regulation of the Pharmaceutical Industry in the Russian Federation. StudNet. No. 9. P. 1556–1560.

5. Flatt V.B., Scott I. (2024) Smart Regulation to Enhance Wealth Creation and Sustainable Capitalism. In: Scott I. (ed.) Sustainable Capitalism: Essential Work for the Anthropocene. Salt Lake City: University of Utah Press. P. 199–207.

6. Gaydin T.Yu., Geller E.V., Rozhnova S.A., Gaydina T.A. (2023) Main State Industrial Policy Measures for the Pharmaceutical Industry of the Russian Federation. Vestnik RGMU. No. 1. P. 59–62. DOI: 10.24075/vrgmu.2023.007

7. Kivarina M.V., Voronin D.S. (2024) Grouping of Indicators of the Financial Condition of Pharmaceutical Industry Enterprises. Zhurnal monetarnoy ekonomiki i menedzhmenta. No. 2. P. 64–69. DOI: 10.26118/2782-4586.2024.57.72.018

8. Roy M. (2020) Politics, Power, Policy, and a Fair Society: The Failed Promise of the Asian Medicine Market. World Review of Political Economy. Vol. 11. Is. 3. P. 357–376. DOI: 10.13169/worlrevipoliecon.11.3.0357

9. Solovyova I.P., Kapelyuk Z.A. (2023) Analiz tsepochki sozdaniya stoimosti rastitel’nykh lekarstvennykh sredstv dlya povysheniya effektivnosti deyatel’nosti kompanii [Analysis of the value chain of herbal medicines to improve the efficiency of the company]. Vserossiyskiye molodezhnyye nauchnyye chteniya im. professora N.N. Protopopova: Sbornik materialov v dvukh chastyakh. Novosibirsk: Sibirskiy universitet potrebitel’skoy kooperatsii. Part 1. P. 128–130.

10. Volin A.Yu., Berkovich M.I., Bragina Z.V. (2020) Product Characteristics of the Pharmaceutical Industry as an Innovative Product. Teoreticheskaya ekonomika. No. 3(63). P. 85–97.